Medication Guidelines for Acute Bronchitis
Drug therapy for acute bronchitis primarily depends on clinical symptoms and underlying etiology. For patients presenting with cough, sputum production, and chest tightness, appropriate antitussive and expectorant medications may be administered, such as Juhong Tanke Liquid, Compound Ambroxol and Clenbuterol Oral Solution, Compound Dextromethorphan Oral Solution, Pholcodine Oral Solution, and Carbocisteine Oral Solution.

If wheezing or dyspnea is present, Compound Methoxyphenamine Capsules may be appropriately prescribed. In addition, nebulized inhalation therapy—using agents such as Budesonide Nebulizer Solution, Salbutamol Nebulizer Solution, or Terbutaline Nebulizer Solution—can help alleviate symptoms.

Etiological treatment targets the causative pathogens of bronchitis. For bacterial infections, antibiotics such as penicillin, amoxicillin, ceftriaxone sodium, azithromycin, or levofloxacin may be selected. When necessary, respiratory secretions can be collected for pathogen culture and antimicrobial susceptibility testing to guide and optimize treatment strategies.

Acute bronchitis is an inflammatory condition of the bronchial mucosa caused by infection with viruses, bacteria, or other pathogens. It is a common and frequently occurring disease in infants and young children, often developing secondary to upper respiratory tract infections and sometimes representing an early manifestation of pneumonia. As the trachea and bronchi are commonly involved simultaneously, the more accurate term is “acute tracheobronchitis.” Clinically, it is characterized by cough—with or without increased bronchial secretions.